RECURSION PHARMACEUTICALS, INC. (RXRX) › Net IncomeRECURSION PHARMACEUTICALS, INC. (RXRX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2019: -$61.88M2020: -$87.01M2021: -$186.48M2022: -$239.48M2023: -$328.07M2024: -$463.66M2025: -$644.76M-$644.76M2019Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$644.76M-39.1%2024-$463.66M-41.3%2023-$328.07M-37.0%2022-$239.48M-28.4%2021-$186.48M-114.3%2020-$87.01M-40.6%2019-$61.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share